Russia’s half-day track at BIO 2013 in April attracted more than its fair share of attention, at an industry conference known for its size and range of activities. ( See [A#14130422007] .) A packed
Biopharmaceutical, medical device, and in vitro diagnostics start-up dealmaking from October through December 2009. Data from Elsevier's Strategic Transactions. Deanna F. Deinzer Financings Biopharma,